VEGFA and central nervous system neoplasm: Overall, when compared to children with solid tumors who underwent treatment with VEGF inhibitors, there were significantly fewer neurologic side effects, with the most common being pain (10%), suggesting that these neurologic adverse events may be intrinsic to CNS tumors and related to disease progression (90, 91, 98).